Codi QR

Study on the predictive efficacy of Ki-67, ER, and PR levels on the effectiveness of neoadjuvant chemotherapy in breast cancer

AimTo investigate the predictive efficacy of Ki-67 antigen (Ki-67), estrogen receptor (ER), and progesterone receptor (PR) levels on the effectiveness of neoadjuvant chemotherapy (NAC) in breast cancer.MethodsA total of 720 breast cancer patients receiving NAC at our hospital from September 2022 to...

Descripció completa

Guardat en:
Autors principals: Lin Lin, Bing Han
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2026-07-01
Col·lecció:Frontiers in Medicine
Matèries:
breast cancer
ER
Ki-67
neoadjuvant chemotherapy
PR
predictive efficacy
Accés en línia:https://www.frontiersin.org/articles/10.3389/fmed.2026.1780629/full
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars